Respiratory Medicine: Bronchiectasis Overview
16 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is bronchiectasis primarily characterized by?

  • Overproduction of mucus without infection
  • Abnormal and permanently dilated airways (correct)
  • Complete obstruction of the bronchi
  • Increased elasticity of the airways
  • What percentage of bronchiectasis cases typically have an identifiable cause?

  • Approximately 25%
  • About 75%
  • Around 50% (correct)
  • Less than 10%
  • Which symptom is commonly associated with bronchiectasis?

  • Constant headaches
  • Productive cough with thick sputum (correct)
  • Sudden weight loss
  • Severe chest tightness without pain
  • What is often a complication of the neutrophilic inflammation in bronchiectasis?

    <p>Persistent airway damage</p> Signup and view all the answers

    Which statement about bronchiectasis prevalence is accurate?

    <p>The global incidence is unknown.</p> Signup and view all the answers

    What is one potential consequence of untreated bronchiectasis?

    <p>Considerable morbidity and early mortality</p> Signup and view all the answers

    Which condition is commonly associated with bronchiectasis?

    <p>Cystic fibrosis</p> Signup and view all the answers

    What role does mucociliary clearance play in bronchiectasis?

    <p>It becomes impaired leading to further problems.</p> Signup and view all the answers

    What is the relationship between age and the incidence of bronchiectasis?

    <p>Bronchiectasis incidence increases with advancing age.</p> Signup and view all the answers

    Which of the following is a primary driver of the economic burden associated with bronchiectasis?

    <p>Hospitalisations related to exacerbations.</p> Signup and view all the answers

    What is a common characteristic of patients with childhood-onset bronchiectasis compared to those with adult-onset?

    <p>They report a worse disease severity.</p> Signup and view all the answers

    Which mechanism is NOT one of the three primary contributors to the pathogenesis of bronchiectasis?

    <p>Pulmonary hypertension.</p> Signup and view all the answers

    What dominates airway inflammation in bronchiectasis?

    <p>Neutrophils.</p> Signup and view all the answers

    Which of the following factors contributes to airway bacterial colonization in bronchiectasis?

    <p>Impaired mucociliary clearance.</p> Signup and view all the answers

    Which clinical feature is highlighted as being not always present in children and adolescents with bronchiectasis?

    <p>Changes in chest auscultation.</p> Signup and view all the answers

    What is the primary focus of laboratory tests in the diagnosis of bronchiectasis?

    <p>To identify the underlying aetiology.</p> Signup and view all the answers

    Study Notes

    Respiratory Medicine: Bronchiectasis

    • Bronchiectasis is an obstructive lung disease involving abnormal, permanent widening of the airways.
    • The disease is characterized by a vicious cycle of neutrophilic inflammation, recurrent infection, and damage to the airway.
    • This further impairs mucociliary clearance (the process of removing mucus from the lungs).
    • Persistent inflammation leads to impaired immunity.
    • The exact prevalence of bronchiectasis globally is unknown due to the lack of standard medical care and poor healthcare access in developing nations.

    Bronchiectasis Epidemiology

    • In the UK, an estimated 212,000 individuals are affected by bronchiectasis.
    • In the US, an estimated 110,000 individuals are affected, with data suggesting an increasing prevalence.
    • Global statistics indicate an increasing incidence of bronchiectasis over recent years, and it can affect individuals of any age.

    Types of Bronchiectasis

    • Cylindrical (fusiform)
    • Saccular
    • Varicose

    Causes of Bronchiectasis

    • Congenital: Deficiency of bronchial wall elements, Pulmonary sequestration

    • Mechanical bronchial obstruction: Foreign body, Inspissated mucus, Post-tuberculous Stenosis, Tumor.

    • Extrinsic: Lymph node, Tumor

    • Post-infective bronchial damage: Bacterial and viral pneumonia (including pertussis, measles, aspiration pneumonia), Granuloma, Tuberculosis, sarcoidosis.

    • Diffuse diseases of the lung parenchyma: Idiopathic pulmonary fibrosis, Immune-related over-responding conditions (allergic bronchopulmonary aspergillosis, post-lung transplant, graft-versus-host disease), Immune deficiency (Panhypogammaglobulinaemia, Selective immunoglobulin deficiencies).

    • Mucociliary clearance defects: Primary ciliary dyskinesia (Kartagener's syndrome), Cystic fibrosis, Acquired conditions like Young's syndrome (azoospermia, sinusitis).

    Pathophysiology of Bronchiectasis

    • The three pivotal mechanisms driving bronchiectasis pathogenesis are recurrent infections, airway obstruction, and peribronchial fibrosis.
    • Neutrophils dominate airway inflammation in bronchiectasis, stimulated by high levels of neutrophil chemoattractants, including interleukin-8 (CXCL-8) and leukotriene B4.
    • Airway bacterial colonization thrives due to impaired mucociliary clearance and the impaired ability of neutrophils to eliminate bacteria.

    Case Scenario

    • A 55-year-old woman presents with a chronic cough producing thick, yellow sputum, sometimes with blood.
    • She reports recurrent episodes of fever and pleuritic chest pain, despite multiple courses of antibiotics.
    • She has experienced shortness of breath with exertion over the past 5 years.
    • Her past medical history includes childhood pneumonia and sinus polyps that required surgery.

    Clinical Features of Bronchiectasis

    • Persistent cough
    • Copious purulent sputum
    • Breathlessness (worsening with disease progression)
    • Hemoptysis (may range from streaking to massive bleeding)
    • Signs of infection (increased sputum volume and purulence, pleuritic chest pain, fever)
    • Auscultation may reveal coarse crackles, high-pitched inspiratory squeaks, rhonchi, and wheezing. Clubbing (thickening of finger and toe tips) may be observed, especially in cystic fibrosis.

    Diagnosis of Bronchiectasis

    • History taking
    • Physical examination
    • Investigations (including pulmonary function tests, chest X-rays, high-resolution computed tomography (HRCT) scans, sputum cultures).
    • Laboratory tests are tailored to identify underlying causes, ensuring treatment addresses both the bronchiectasis and any associated conditions.
    • Specific tests may only be available at specialized centers.

    Imaging

    • Chest X-rays often show nonspecific findings such as increased markings, linear atelectasis, or loss of volume.
    • HRCT scans are generally the most accurate imaging modality, demonstrating typical "tram-tracking" or "signet-ring" features in the dilated or thick-walled airways.

    Management of Bronchiectasis

    • Identify and treat the underlying cause (e.g., cystic fibrosis, immunodeficiencies).
    • Improve tracheobronchial clearance (e.g., airway clearance techniques, medications).
    • Control infection (e.g., antibiotics for exacerbations).
    • Reverse airflow obstruction (e.g., medications, sometimes surgery).
    • Immunoglobulin replacement, steroids and antifungals (ABPA).

    Treatment of Bronchiectasis

    • Medications include antibiotics for exacerbations, respiratory fluoroquinolones (levofloxacin or moxifloxacin) tailored to sputum culture results.
    • Systemic glucocorticoids and antifungal therapy (voriconazole or itraconazole) for allergic bronchopulmonary aspergillosis (ABPA).
    • Bronchopulmonary hygiene measures (cough promotion, postural drainage, chest physiotherapy) are crucial.
    • Consideration of surgery (lobectomy for localized severe disease or lung transplantation) is also taken into account.

    Pulmonary Disease Management

    • Airway clearance techniques, including respiratory physiotherapy, percussion, vibration, deep breathing, and forced coughing, are an integral part of management.
    • Nebulized recombinant human DNase (rhDNase) aids in reducing sputum viscosity.
    • Hypertonic saline draws water to the cell surface and lessens viscosity.
    • Inhaled mannitol enhances mucociliary clearance.
    • Long-term azithromycin has an immunomodulatory effect in cystic fibrosis patients.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    Description

    This quiz explores bronchiectasis, an obstructive lung disease characterized by the permanent widening of the airways. Learn about its epidemiology, types, and the challenges in managing this condition globally. Test your knowledge on the impact of bronchiectasis on lung function and public health.

    More Like This

    6. Bronchiectasis
    10 questions

    6. Bronchiectasis

    IngeniousCynicalRealism8387 avatar
    IngeniousCynicalRealism8387
    Use Quizgecko on...
    Browser
    Browser